Characteristics Associated With Decreased or Increased Mortality Risk From Glycemic Therapy Among Patients With Type 2 Diabetes and High Cardiovascular Risk: Machine Learning Analysis of the ACCORD Trial. [electronic resource]
- Diabetes care 03 2018
- 604-612 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1935-5548
10.2337/dc17-2252 doi
Adult Aged Biomarkers--blood Blood Glucose--metabolism Body Mass Index Cardiovascular Diseases--epidemiology Diabetes Mellitus, Type 2--complications Double-Blind Method Follow-Up Studies Glycated Hemoglobin--metabolism Humans Machine Learning Middle Aged Risk Factors Sample Size Sensitivity and Specificity Treatment Outcome